fda compounding semaglutide update As of February 21, 2025, the updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A The End of Compounded Semaglutide:

The triple-receptor design ensures multiple metabolic pathways are engaged regardless of starting composition, which is one reason the medication produces such consistent results across diverse body types

Domestic drugs Mazdutide and Ecnoglutide exhibit high rates of gastrointestinal toxicities like nausea and vomiting, but their overall AE rates are not much higher than placebo, and they keep discontinuation rates particularly well-controlled

The 6.6 percentage-point gain from adding cagrilintide to semaglutide is the cleanest existing read on what amylin layering buys you on top of an incretin agonist

Smaller meals, eating more slowly, lighter and less greasy foods, and steady hydration all help